Подагра. Диссертация Мишко МЮ. 2 оглавление введение глава обзор литературы значение внешнесредовых и генетических факторов в развитии гиперурикемии и подагры
 Скачать 5.03 Mb.
|
|
– DOI 10.1074/jbc.C800156200 // J Biol Chem. – 2008. – Vol. 283 (40). – P. 26834–26838. 129. Polymorphisms in DNA repair genes increase the risk for type 2 diabetes mellitus and hypertension / S. Das, S. Purkayastha, H. Roy [et al.]. – DOI 10.1515/bmc-2018- 0008 // BioMol Concepts. – 2018. – Vol. 9. – P. 80–93. 130. Population-specific association between ABCG2 variants and tophaceous disease in people with gout / W. He, A. Phipps-Green, L.K. Stamp [et al.]. – DOI 10.1186/s13075-017-1254-8 // Arthritis Research & Therapy. – 2017. – Vol. 19 (1). – P. 43. 131. Purine-rich foods, dairy and protein intake, and the risk of gout in men / H.K. Choi, K. Atkinson, E.W. Karlson [et al.]. – DOI 10.1056/NEJMoa035700 // N Engl J Med. – 2004. – Vol. 350 (11). – P. 1093–1103. 132. Rai V. Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations. – DOI 0.7314/apjcp.2015.16.18.8093 // Asian Pac J Cancer Prev. – 2015. – Vol. 16 (18). – P. 8093–8100. 133. Rai V. Folate pathway gene MTHFR C677T polymorphism and risk of lung cancer in Asian populations / V. Rai. – DOI 10.7314/apjcp.2014.15.21.9259 // Asian Pac J Cancer Prev. – 2014. – Vol. 15 (21). – P. 9259–9264. 134. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study / D.J. Hunter, M. York, C.E. Chaisson [et al.] // J Rheumatol. – 2006. – Vol. 33 (7). – P. 1341–1345. 135. Regulation of uric acid metabolism and excretion / J. Maiuolo, F. Oppedisano, S. Gratteri [et al.]. – DOI 10.1016/j.ijcard.2015.08.109 // Int J Cardiol. – 2016. – Vol. 213. – P. 8–14. 162 136. Relationship between plasma total homocysteine level and dietary caffeine and vitamin B6 intakes in pregnant women / M. Shiraishi, M. Haruna, M. Matsuzaki [et al.]. – DOI 10.1111/nhs.12080 // Nurs Health Sci. – 2014. – Vol. 16 (2). – P. 164–170. 137. Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians / V.S. Voruganti, N. Franceschini, K. Haack [et al.]. – DOI 10.1038/ejhg.2013.264 // Eur J Human Genetics. – 2014. – Vol. 22 (7). – P. 938–943. 138. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case-control sample sets / J.E. Hollis- Moffatt, X. Xu, N. Dalbeth [et al.]. – DOI 10.1002/art.24938 // Arthritis Rheum. – 2009. – Vol. 60 (11). – P. 3485–3492. 139. Sampath H. Roles of OGG1 in transcriptional regulation and maintenance of metabolic homeostasis / H. Sampath, R.S. Lloyd. – DOI 10.1016/j.dnarep.2019.102667 // DNA Repair (Amst). – 2019. – Vol. 81. – P. 102667. 140. Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI / A. Brandstatter, S. Kiechl, B. Kollerits [et al.]. – DOI 10.2337/dc08-0349 // Diabetes Care. – 2008. – Vol. 31. – P. 1662–1667. 141. Significant association between methylenetetrahydrofolate reductase 677T allele and hyperuricemia among adult Japanese subjects / S. Itou, Y. Goto, K. Suzuki [et al.]. – DOI 10.1016/j.nutres.2009.10.006 // Nutr Res. – 2009. – Vol. 29 (10). – P. 710–715. 142. Singh J.A. Gout epidemiology and comorbidities / J.A. Singh, A. Gaffo. – DOI 10.1016/j.semarthrit.2020.04.008 // Semin Arthritis Rheum. – 2020. – Vol. 50 (3S). – P. S11 –S16. 143. Terkeltaub R. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics / R. Terkeltaub, D.A. Bushinsky, M.A. Becker. – DOI 10.1186/ar1909 // Arthr. Res. Ther. – 2006. – Vol. 8 (1). – P. 4. 144. The ABCG2 Polymorphism rs2725220 Is Associated with Hyperuricemia in the Korean Population / J.W. Sull, S.J. Yang, S. Kim, S.H. Jee. – DOI 10.5808/GI.2014.12.4.231 // Genomics Inform. – 2014. – Vol. 12 (4). – P. 231–235. 163 145. The C677 Mutation in Methylene Tetrahydrofolate Reductase Gene: Correlation with Uric Acid and Cardiovascular Risk Factors in Elderly Korean men / Y.S. Hong, M.J. Lee, K.H. Kim [et al.]. – DOI 10.3346/jkms.2004.19.2.209 // J Korean Med Sci. – 2004. – Vol. 19 (2). – P. 209–213. 146. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men / M. Zuo, H. Nishio, M.J. Lee [et al.]. – DOI 10.1007/s100380070037 // J Hum Genet. – 2000. – Vol. 45 (4). – P. 257–262. 147. The genetics of hyperuricaemia and gout / A.M. Reginato, D.B. Mount, I. Yang, H.K. Choi – DOI 10.1038/nrrheum.2012.144 // Nature Reviews Rheumatology. – 2012. – Vol. 8 (10). – P. 610–621. 148. The integration of genome-based information for common diseases into health policy and healthcare as a major challenge for Public Health Genomics: the example of the methylenetetrahydrofolate reductase gene in non-cancer diseases / S. Boccia, A. Brand, H. Brand, G. Ricciardi. – DOI 10.1016/j.mrfmmm.2008.10.003 // Mutat Res. – 2009. – Vol. 667 (1-2). – P. 27–34. 149. The roles of base excision repair enzyme OGG1 in gene expression / R. Wang, W. Hao, L. Pan. [et al.]. – DOI 10.1007/s00018-018-2887-8 // Cell Mol Life Sci. – 2018. – Vol. 75 (20). – P. 3741–3750. 150. Thottam G.E. Gout and Metabolic Syndrome: a Tangled Web. Review / G.E. Thottam, S. Krasnokutsky, M.H. Pillinger. – DOI 10.1007/s11926-017-0688-y // Curr Rheumatol Rep. – 2017. – Vol. 19 (10). – P. 60. 151. Torres R.J. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome / R.J. Torres, J.G. Puig. – DOI 10.1186/1750-1172-2-48 // Orphanet J Rare Dis. – 2007. – Vol. 2. – P. 48. 152. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion / R.J. Torres, E. de Miguel, R. Bailén [et al.]. – DOI 10.3899/jrheum.140126 // J Rheumatol. – 2014. – Vol. 41 (9). – P. 1863 –1870. 164 153. Unapparent hypoxanthine-guanine phosphoribosyltransferase deficiency / R.J. Torres, S. Puente, A. Menendez, N. Fernandez-Garcia. – DOI 10.1016/j.cca.2017.08.002 // Clin Chim Acta. – 2017. – Vol. 472. – P. 136–138. 154. Understanding the structure-function relationship of HPRT1 missense mutations in association with Lesch-Nyhan disease and HPRT1-related gout by in silico mutational analysis / A.K. Agrahari, P.M. Krishna, K.M. Praveen. [et al.]. – DOI 10.1016/j.compbiomed.2019.02.014 // Comput Biol Med. – 2019. – Vol. 107. – P. 161– 171. 155. Updated 2016 EULAR evidence-based recommendations for the management of gout / P. Richette, M. Doherty, E. Pascual [et al.]. – DOI 10.1136/annrheumdis-2016- 209707 // Ann Rheum Dis. – 2017. – Vol. 76 (1). – P. 29–42. 156. Yahaya T.O. A Review of Type 2 Diabetes Mellitus Predisposing Genes. / T.O. Yahaya, T.F. Salisu. – DOI 10.2174/1573399815666181204145806 // Curr Diabetes Rev. – 2019. – Vol. 16 (1). – P. 52–61. 157. Yokose C. The role of diet in hyperuricemia and gout / C. Yokose, N. McCormick, H.K. Choi. – DOI 10.1097/BOR.0000000000000779 // Curr Opin Rheumatol. – 2021. – Vol. 33 (2). – P. 135–144. 158. Yuan Y. Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis / Y. Yuan, W. Shao, Y. Li. – DOI 10.1007/s00296- 017-3650-4 // Rheumatol Int. – 2017. – Vol. 37 (4). – P. 557–569. 159. Zhu Y. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007 –2008 / Y. Zhu, B.J. Pandya, H.K. Choi. – DOI 10.1002/art.30520 // Arthritis Rheum. – 2011. – Vol. 63 (10). – P. 3136 –3141. |